Medicilon IncMedicilon IncMedicilon IncMedicilon Inc
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Integrated Projects
      • Antibody-Drug-Antibody (ADC)
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
      • Molecular Imaging & Radiochemistry
      • OINDP Development
      • Preclinical Ophthalmic Research Platform
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic Mouse Models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthetic Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
      • OINDP Development
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Bioanalytical Services
      • Large Molecule Bioanalysis
      • Small Molecule Bioanalysis
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
    • Drug Safety Evaluation
      • Inhalation Toxicity Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Medicilon Events
    • Media Coverage
    • Featured Stories
  • Contact

Ames Test

Home Featured Stories
NextPrevious

Ames Test

By medicilon | Featured Stories | 23 June, 2020 |

ICH recommended standard genotoxicity test combination
Combination one

a.Ames
b. In vitro chromosome aberration test or in vitro micronucleus test or in vitro mouse lymphoma tk test, one of these three tests can be selected.
c. In vivo micronucleus test or in vivo bone marrow cell chromosome aberration test; taking peripheral blood lymphocytes for cytogenetic analysis after animal administration is acceptable, but not commonly used.

Combination two

a.Ames
b. Two different tissues are used for in vivo genotoxicity assessment, usually including in vivo micronucleus test and another in vivo test. The second intra-individual test usually chooses to assess the DNA strand breaks in the animal’s liver.
Ames is the most relevant in vitro test for carcinogen detection.

Bacterial reverse mutation (Ames) test
• Used to detect genetic mutations caused by DNA damage. By detecting the ability of the test substance to cause mutations in certain specially constructed mutants of the test strain, that is, causing the strain to mutate from histidine/tryptophan-dependent to prototrophic type, it is judged whether the test substance is a mutagen.
• The test should be conducted simultaneously with and without s9 metabolic activation system.
• ※ Adding trace amounts of histidine or tryptophan to the agar medium where the bacteria are cultivated allows the bacteria to grow a few hours before, manifesting as background moss. When the added histidine/tryptophan is exhausted, only the mutated bacteria can continue to grow into visible mutant colonies.

Different types of Ames tests

GLP test uses standard Ames test.
The tests commonly used in the early stage of drug screening are Mini-Ames test, Micro-Ames test, AmesII test, etc., which is characterized by low dosage.
The Mini/Micro Ames test usually selects 2 strains (ie, TA98 and TA100, which can detect 98% mutagen). In order to eliminate the possibility of another 2%, the same 5 strains as the standard Ames test can be selected.
The AmesII test uses strain TA98 and mixed strains TA7001 to 7006. After pre-cultivation and serial dilution of the bacteria and the test substance, they are cultured at 30°C overnight, and then inoculated with each selective reagent 5-FU and pH sensitive agent bromocresol On the purple 384 well, the degree of yellowing of the culture medium was detected by an ultraviolet spectrophotometer to judge the mutagenicity of the test substance.

Ames test flow

Test strain (Ames Test System)
At least 5 strains should be selected

• TA1535
• TA1537 or TA97 or TA97a
• TA98
• TA100
• WP2 uvrA or WP2 uvrA (pKM101) or TA102

Each strain has different mutations in the operon encoding histidine/tryptophan biosynthesis.
More laboratories abroad choose WP2, while domestically use TA102.

Test strain genotype and mutation type

Test strain genotype and detection sensitivity
The presence of Rfa membrane mutations increases the permeability of cell membranes to macromolecular chemicals
The excision repair function of uvrB-strains is defective, and the strains cannot excise DNA adducts. Yes, these strains are sensitive to the mutagenicity and bacterial toxicity of a large number of mutagen.
The plasmid pKM101 contains the muc+ gene, which participates in the DNA repair pathway induced by DNA damage, while giving bacteria resistance to the mutagenicity of the mutagen while increasing the susceptibility to mutation. Strains containing plasmid pKM101 had a higher number of spontaneously reverted mutant colonies.

TA1537, TA97, and TA97a all contain cytosine repeats and are located in the mutation-sensitive sites within the corresponding histidine target sites. They are similarly sensitive to frameshift mutagens that cause base deletions in these frameshift hotspots.

TA98 and TA100 are sensitive to most mutagenic agents (data shows that 98% of these two strains tested positive for mutagen, so only these two strains can be detected in the preliminary screening test.)
Hydroxyanthraquinones can only be detected by strain TA1537
Oxidizing mutants and DNA cross-linking agents hydrazine can only be detected by strains TA102, WP2urA, WP2uvrA (pKM101) containing AT site mutations
Both strains TA1535 and TA100 have a fever-base substitution mutation at the hisG46 gene locus, the only difference is that TA100 contains the pKM101 plasmid, thereby increasing mutation sensitivity. However, the expert team showed through a large amoun types of Ames tests t of data that about 5% of the 659 known mutagens can only be detected by TA1535, not TA100.

Choice of solvent
• Water: water-soluble compounds
• Dimethyl sulfoxide (DMSO): No water-soluble compound preferred
• Ethanol
• Acetone
• Infrequently used vehicles: set up a parallel negative control

Ames test
NextPrevious

News

  • Medicilon Events
  • Media Coverage
  • Featured Stories

Tags

ADME (11) animal model (3) Animal Models (46) API (3) API process (3) BIAcore 8K (3) bioanalytical testing (3) Clinical Trails (2) consistency evaluation (3) COVID-19 (3) CRO (13) CRO company (8) CRO industry (6) diabetes treatment (3) Drug Discovery (7) drug safety cro (2) Drug Safety Evaluation (3) Elisa Assay (4) Formulation Research (3) GLP (3) green chemistry (3) IND (2) IND Application (3) IND Filing (5) IPO (3) LC-MS (4) Ligand Binding Assay (4) Medicilon Inc. (2) neurological disease (4) neurological diseases (4) neurological disorder (5) neurological disorders (4) PDX model (3) Peptide Drugs (3) Pharmacokinetics (7) pharmacokinetics research (6) pk study (2) Preclinical Research (6) PROTAC (4) Protein expression (4) Protein Purification (8) SAPA (5) Synthetic Biology (4) T cell (3) Western Blot Analysis (2)

Top Posts

  • 14 August, 2017

    Factors Affecting Pharmacokinetics of Drugs

  • 14 October, 2016

    Preclinical Drug Development Process

  • 14 February, 2017

    IND Enabling Studies FDA

Share

About Us

  • Medicilon Overview
  • Executive Team
  • CEO Message
  • Company History
  • Corporate Culture
  • Honor

Services

  • Chemistry
  • Biology
  • Bioanalytical
  • Drug Safety Evaluation
  • Formulation Development
  • Pharmacology
  • Pharmacokinetic
  • Integrated Projects

Customer Center

  • Customer Reviews
  • Download Center
  • Intellectual Property Protection
  • New Models of Collaboration

Contact Us

Shanghai Medicilon Inc.

Address: No. 585, Chuanda Road, Pudong, Shanghai, 201200, China
Email: Marketing@medicilon.com
Website: www.medicilon.com

Copyright 2017 Shanghai Medicilon inc. | All Rights Reserved Privacy Policy
  • Languages
  • 中国日本대한민국
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Integrated Projects
      • Antibody-Drug-Antibody (ADC)
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
      • Molecular Imaging & Radiochemistry
      • OINDP Development
      • Preclinical Ophthalmic Research Platform
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic Mouse Models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthetic Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
      • OINDP Development
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Bioanalytical Services
      • Large Molecule Bioanalysis
      • Small Molecule Bioanalysis
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
    • Drug Safety Evaluation
      • Inhalation Toxicity Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Medicilon Events
    • Media Coverage
    • Featured Stories
  • Contact
Medicilon Inc